References
Key articles
van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62.Full text Abstract
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6.Full text Abstract
Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.Full text Abstract
Reference articles
1. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am. 2008 May;26(2):281-317. Abstract
2. Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010 Jan;10(1):32-42. Abstract
3. Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010 Nov;126(5):952-60. Abstract
4. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010 Jul;23(3):467-92.Full text Abstract
5. Brouwer MC, van de Beek D. Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis. 2018 Feb;31(1):78-84. Abstract
6. Paireau J, Chen A, Broutin H, et al. Seasonal dynamics of bacterial meningitis: a time-series analysis. Lancet Glob Health. 2016 Jun;4(6):e370-7.Full text Abstract
7. van Kessel F, van den Ende C, Oordt-Speets AM, et al. Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review. J Glob Health. 2019 Jun;9(1):010411.Full text Abstract
8. GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Dec;17(12):1061-82.Full text Abstract
9. Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. Abstract
10. Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014 Sep;14(9):813-9. Abstract
11. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009 Jan 15;360(3):244-56.Full text Abstract
12. Olarte L, Barson WJ, Barson RM, et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis. 2015 Sep 1;61(5):767-75.Full text Abstract
13. Peterson ME, Li Y, Bita A, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019 Jun;9(1):010409.Full text Abstract
14. Ladhani SN, Ramsay M, Borrow R, et al. Enter B and W: two new meningococcal vaccine programmes launched. Arch Dis Child. 2016 Jan;101(1):91-5.Full text Abstract
15. Whittaker R, Dias JG, Ramliden M, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine. 2017 Apr 11;35(16):2034-41.Full text Abstract
16. Oordt-Speets AM, Bolijn R, van Hoorn RC, et al. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS One. 2018 Jun 11;13(6):e0198772.Full text Abstract
17. Schuchat A, Robinson K, Wenger JD, et al; Active Surveillance Team. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997 Oct 2;337(14):970-6.Full text Abstract
18. Centers for Disease Control and Prevention. Meningitis: resources for healthcare professionals. August 2019 [internet publication].Full text
19. Koopmans MM, Brouwer MC, Bijlsma MW, et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis. 2013 Jul;57(2):247-53.Full text Abstract
20. van Veen KE, Brouwer MC, van der Ende A, et al. Bacterial meningitis in diabetes patients: a population-based prospective study. Sci Rep. 2016 Nov 15;6:36996.Full text Abstract
21. van Samkar A, Brouwer MC, Schultsz C, et al. Capnocytophaga canimorsus meningitis: three cases and a review of the literature. Zoonoses Public Health. 2016 Sep;63(6):442-8. Abstract
22. van Samkar A, Brouwer MC, van der Ende A, et al. Streptococcus equi meningitis. Clin Microbiol Infect. 2016 Jan;22(1):e3-4.Full text Abstract
23. van Samkar A, Brouwer MC, van der Ende A, et al. Campylobacter fetus meningitis in adults: report of 2 cases and review of the literature. Medicine (Baltimore). 2016 Feb;95(8):e2858.Full text Abstract
24. Zwijnenburg PJ, van der Poll T, Roord JJ, et al. Chemotactic factors in cerebrospinal fluid during bacterial meningitis. Infect Immun. 2006 Mar;74(3):1445-51.Full text Abstract
25. Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020 Sep 25;69(9):1-41.Full text Abstract
26. McNamara LA, Shumate AM, Johnsen P, et al. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015 May;135(5):798-804.Full text Abstract
27. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004 Oct 28;351(18):1849-59.Full text Abstract
28. van Veen KE, Brouwer MC, van der Ende A, et al. Bacterial meningitis in patients with HIV: a population-based prospective study. J Infect. 2016 Mar;72(3):362-8. Abstract
29. Adriani KS, Brouwer MC, van de Beek D. Risk factors for community-acquired bacterial meningitis in adults. Neth J Med. 2015 Feb;73(2):53-60.Full text Abstract
30. Jallow S, Madhi SA Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children. Expert Rev Vaccines. 2017 May;16(5):453-65. Abstract
31. Tebruegge M, Curtis N. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev. 2008 Jul;21(3):519-37.Full text Abstract
32. Costerus JM, Brouwer MC, van der Ende A, et al. Community-acquired bacterial meningitis in adults with cancer or a history of cancer. Neurology. 2016 Mar 1;86(9):860-6. Abstract
33. Wilson-Clark SD, Squires S, Deeks S, et al. Bacterial meningitis among cochlear implant recipients - Canada, 2002. MMWR Suppl. 2006 Apr 28;55(1):20-4. Abstract
34. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997 Oct;16(10):979-83. Abstract
35. Collins JP, Crowe SJ, Ortega-Sanchez IR, et al. Use of the pfizer pentavalent meningococcal vaccine among persons aged ≥10 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2024 Apr 18;73(15):345-50.Full text Abstract
36. Kobayashi M, Leidner AJ, Gierke R, et al. Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Sep 12;73(36):793-8.Full text Abstract
37. National Institute for Health and Care Excellence (UK). Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].Full text
38. van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62.Full text Abstract
39. Chávez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005 Jun;52(3):795-810. Abstract
40. Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016 Mar;16(3):339-47. Abstract
41. Oostenbrink R, Moons KG, Theunissen CC, et al. Signs of meningeal irritation at the emergency department: how often bacterial meningitis? Pediatr Emerg Care. 2001 Jun;17(3):161-4. Abstract
42. McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38.Full text Abstract
43. Garges HP, Moody MA, Cotten CM, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics. 2006 Apr;117(4):1094-100. Abstract
44. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Abstract
45. Arendt K, Demaerschalk BM, Wingerchuk DM, et al. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. Abstract
46. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. Abstract
47. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.Full text Abstract
48. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.Full text Abstract
49. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.Full text Abstract
50. Schuurman T, de Boer RF, Kooistra-Smid AM, et al. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol. 2004 Feb;42(2):734-40.Full text Abstract
51. World Health Organization & Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis caused by neisseria meningitidis, streptococcus pneumoniae, and haemophilus influenzae: WHO manual, 2nd ed. 2011 [internet publication].Full text
52. Cartwright K, Reilly S, White D, et al. Early treatment with parenteral penicillin in meningococcal disease. BMJ. 1992 Jul 18;305(6846):143-7.Full text Abstract
53. Gerdes LU, Jørgensen PE, Nexø E, et al. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest. 1998 Aug;58(5):383-93. Abstract
54. Sormunen P, Kallio MJ, Kilpi T, et al. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr. 1999 Jun;134(6):725-9. Abstract
55. Wei TT, Hu ZD, Qin BD, et al. Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis: a systematic review and meta-analysis. Medicine (Baltimore). 2016 Mar;95(11):e3079.Full text Abstract
56. Vikse J, Henry BM, Roy J, et al. The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis. Int J Infect Dis. 2015 Sep;38:68-76.Full text Abstract
57. Henry BM, Roy J, Ramakrishnan PK, et al. Procalcitonin as a serum biomarker for differentiation of bacterial meningitis from viral meningitis in children: evidence from a meta-analysis. Clin Pediatr (Phila). 2016 Jul;55(8):749-64. Abstract
58. American Society for Clinical Pathology. Thirty five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. Jul 2021 [internet publication].Full text
59. Weisfelt M, van de Beek D, Spanjaard L, et al. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006 Feb;5(2):123-9. Abstract
60. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. Abstract
61. Deisenhammer F, Bartos A, Egg R, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006 Sep;13(9):913-22.Full text Abstract
62. Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis. Chapter 10: PCR for detection and characterization of bacterial meningitis pathogens: Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. Section V: real-time PCR. April 2016 [internet publication].Full text
63. Centers for Disease Control and Prevention. Meningococcal disease (Neisseria meningitidis): 2015 case definition. April 2021 [internet publication].Full text
64. Le Saux N; Canadian Paediatric Society. Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than 2 months of age. October 2020 [internet publication].Full text
65. Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6.Full text Abstract
66. Proulx N, Fréchette D, Toye B, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005 Apr;98(4):291-8.Full text Abstract
67. Zasowski EJ, Bassetti M, Blasi F, et al. A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections. Chest. 2020 Sep;158(3):929-38.Full text Abstract
68. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59.Full text Abstract
69. National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].Full text
70. Sudarsanam TD, Rupali P, Tharyan P, et al. Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev. 2017 Jun 14;(6):CD005437.Full text Abstract
71. de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56.Full text Abstract
72. van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. Abstract
73. Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.Full text Abstract
74. Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209.Full text Abstract
75. Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23. Abstract
76. Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. Abstract
77. Ogunlesi TA, Odigwe CC, Oladapo OT. Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. Cochrane Database Syst Rev. 2015 Nov 11;(11):CD010435.Full text Abstract
78. Nadel S, Kroll JS. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev. 2007 Jan;31(1):71-83.Full text Abstract
79. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update. Crit Care Med. 2018 Jun;46(6):997-1000.Full text Abstract
80. Maconochie IK, Bhaumik S. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev. 2016 Nov 4;(11):CD004786.Full text Abstract
81. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96. Abstract
82. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.Full text Abstract
84. Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.
85. Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2022 [internet publication].Full text
86. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78. Abstract
87. Practice guidelines for central venous access 2020: an updated report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2020 Jan;132(1):8-43.Full text Abstract
88. Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91. Abstract
89. Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.Full text Abstract
90. Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4. Abstract
91. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text Abstract
92. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021 Apr;161:115-51.Full text Abstract
93. Colquhoun MC, Handley AJ, Evans TR. ABC of resuscitation. 5th ed. London: BMJ Publishing Group; 2004.
94. Chrimes N, Higgs A, Hagberg CA, et al. Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societies. Anaesthesia. 2022 Dec;77(12):1395-415.Full text Abstract
95. Peltola H, Roine I, Fernández J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007 Nov 15;45(10):1277-86.Full text Abstract
96. Wall EC, Ajdukiewicz KM, Bergman H, et al. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database Syst Rev. 2018 Feb 6;(2):CD008806.Full text Abstract
97. Carreras-Abad C, Cochet M, Hall T, et al. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study. Health Technol Assess. 2019 Dec;23(67):1-40.Full text Abstract
98. Meningitis Research Foundation. Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults. January 2016 [internet publication].Full text
99. Hoogman M, van de Beek D, Weisfelt D, et al. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1092-6.Full text Abstract
100. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993 May;12(5):389-94. Abstract
101. Grimwood K, Anderson VA, Bond L, et al. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics. 1995 May;95(5):646-56. Abstract
102. Koomen I, Grobbee DE, Roord JJ, et al. Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics. 2003 Nov;112(5):1049-53. Abstract
103. Koomen I, Grobbee DE, Roord JJ, et al. Prediction of academic and behavioural limitations in school-age survivors of bacterial meningitis. Acta Paediatr. 2004 Oct;93(10):1378-85. Abstract
104. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993 Jan 7;328(1):21-8.Full text Abstract
105. Geiseler PJ, Nelson KE, Levin S, et al. Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. Rev Infect Dis. 1980 Sep-Oct;2(5):725-45. Abstract
106. Sharip A, Sorvillo F, Redelings MD, et al. Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr Infect Dis J. 2006 Mar;25(3):191-4. Abstract
107. Brooks R, Woods CW, Benjamin DK Jr, et al. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis. 2006 Jul 1;43(1):49-54.Full text Abstract
108. Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis. 1995 Dec;21(6):1390-7. Abstract
Use of this content is subject to our disclaimer